股票代码：000638 股票简称：万方发展 上市地点：深圳证券交易所
万方城镇投资发展股份有限公司
重大资产出售及重大资产购买报告书（草案）上市公司名称：万方城镇投资发展股份有限公司
股票上市地点：深圳证券交易所
股票简称：万方发展
股票代码：000638
重大资产出售交易对方 住址/通讯地址
刘志峰 黑龙江省庆安县大罗镇东平村陆粉房屯X号
重大资产购买交易对方 住址/通讯地址
易刚晓 成都市武侯区致民路36号X楼X号
肖倚天 长春市朝阳区南湖街道湖东街委X组
白亭兰 成都市武侯区人民南路四段46号X栋X单元X楼X号
杨骁 四川省双流县华阳南湖西路175号X栋X单元X号
尹连山 重庆市江北区野水沟191号X单元X号
马嘉霖 广东省深圳市福田区景田路18号聚豪园秀丽阁X房
广州广发信德一期健康产业投资 广州市天河区天河北路大都会广场183-187号1602
企业（有限合伙）
上海复星长征医学科学有限公司 上海市宝山区城银路830号
珠海康远投资企业（有限合伙） 广州市天河北路大都会广场16楼
尧东、王艺儒等13名自然人 详见本报告书“第三节 交易对方基本情况”
独立财务顾问
二零一七年一月
交易各方声明
一、公司声明
本公司及本公司全体董事、监事及高级管理人员保证本报告书的内容真实、准确和完整，并对本报告书中的虚假记载、误导性陈述或者重大遗漏承担个别或连带的法律责任。如本次重大资产重组因涉嫌所提供或者披露的信息存在虚假记载、误导性陈述或者重大遗漏，被司法机关立案侦查或者被中国证监会立案调查的，在案件调查结论明确之前，全体董事、监事及高级管理人员将暂停与本公司相关的一切权益，包括但不限于领取薪酬、转让在公司拥有权益的股份等。
本次重大资产重组完成后，本公司经营与收益的变化，由本公司自行负责；因本次重大资产重组引致的投资风险，由投资者自行负责。
本次交易相关事项的生效和完成尚待有关审批机关的批准或核准。审批机关对于本次交易相关事项所做的任何决定或意见，均不表明其对公司股票的价值或投资者的收益作出实质性判断或保证。
投资者若对本报告书存在任何疑问，应咨询自己的股票经纪人、律师、会计师或其他专业顾问。
二、交易对方声明
根据相关规定，作为公司本次重大资产出售的交易对方刘志峰及本次重大资产购买的交易对方易刚晓、广发信德、珠海康远、复星长征及肖倚天等18名自然人就其对本次交易提供的所有相关信息，分别承诺如下：
“本公司/本企业/本人已向上市公司及为本次重大资产重组服务的中介机构提供了有关本次重大资产重组的相关信息和文件（包括但不限于原始书面材料、副本材料或口头证言等）。本公司/本企业/本人保证：所提供的文件资料的副本或复印件与正本或原件一致，且该等文件资料的签字与印章都是真实的；保证所提供信息和文件真实、准确和完整，不存在虚假记载、误导性陈述或者重大遗漏，并对所提供信息的真实性、准确性和完整性承担个别及连带的法律责任。
在参与本次重大资产重组期间，本公司/本企业/本人将依照相关法律、法规、规章、中国证券监督管理委员会和深圳证券交易所的有关规定，及时向上市公司披露有关本次交易的信息，并保证该等信息的真实性、准确性和完整性，保证该等信息不存在虚假记载、误导性陈述或者重大遗漏。
如本次交易所提供或披露的信息涉嫌虚假记载、误导性陈述或者重大遗漏，被司法机关立案侦查或者被中国证监会立案调查的，在形成调查结论以前，不转让在该上市公司拥有权益的股份（如有）。
以上承诺是本公司/本企业/本人的真实意思表示，如违反上述承诺及声明，本公司/本企业/本人将愿意承担个别和连带的法律责任。特此承诺！”
三、证券服务机构声明
根据相关规定，作为公司本次重大资产重组的证券服务机构对于本次交易申请文件的相关信息，分别承诺：
“如本次重组申请文件存在虚假记载、误导性陈述或重大遗漏，本公司/本所未能勤勉尽责的，将承担连带赔偿责任。”
目录
交易各方声明·······································································································2
一、公司声明···································································································2
二、交易对方声明·····························································································2
三、证券服务机构声明·······················································································3
目录·················································································································4
释义·················································································································9
重大事项提示······································································································13
一、本次交易方案····························································································13
二、标的资产的评估及作价················································································14
三、业绩承诺及补偿·························································································15
四、业绩奖励··································································································16
五、本次交易构成重大资产重组···········································································20六、本次交易不构成关联交易··············································································21 七、本次交易不属于《重组管理办法》第十三条规定的借壳上市·································21八、本次交易后上市公司股票仍具备上市条件·························································21九、本次交易对上市公司的影响···········································································21十、本次交易尚需履行的程序··············································································27十一、本次交易相关方作出的重要承诺··································································28十二、本次重组中对中小投资者权益保护的安排 ······················································34 十三、其他重大事项·························································································35重大风险提示······································································································49 一、与本次交易相关的风险················································································49二、本次交易完成后的行业与业务风险··································································51 三、其他风险··································································································52第一节本次交易概述···························································································55 一、本次交易的背景和目的················································································55二、本次交易的决策过程及尚需取得的授权和批准 ···················································58 三、本次交易的具体方案··········································································
